Accordingly, amplification of two oncogenes associated with p53 regulation, MDM2, and MDM4, as well as polymorphisms in these genes have been associated with RB development and/or survival (Laurie et al., 2006; de Oliveira Reis et al., 2012). The gene discussed is MDM2; the disease is retinoblastoma.